Zevra Therapeutics, Inc. (ZVRA)
12.96
-0.54
(-4.00%)
USD |
NASDAQ |
Jun 11, 16:00
12.96
0.00 (0.00%)
After-Hours: 19:19
Zevra Therapeutics SG&A Expense (Quarterly) : 20.78M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 20.78M |
| December 31, 2025 | 20.35M |
| September 30, 2025 | 16.94M |
| June 30, 2025 | 20.78M |
| March 31, 2025 | 19.54M |
| December 31, 2024 | 16.12M |
| September 30, 2024 | 16.21M |
| June 30, 2024 | 12.60M |
| March 31, 2024 | 9.931M |
| December 31, 2023 | 14.66M |
| September 30, 2023 | 5.818M |
| June 30, 2023 | 6.612M |
| March 31, 2023 | 7.227M |
| December 31, 2022 | 4.772M |
| September 30, 2022 | 3.974M |
| June 30, 2022 | 3.558M |
| March 31, 2022 | 2.734M |
| December 31, 2021 | 2.556M |
| September 30, 2021 | 1.948M |
| June 30, 2021 | 2.305M |
| March 31, 2021 | 1.892M |
| December 31, 2020 | 2.528M |
| September 30, 2020 | 1.429M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.719M |
| March 31, 2020 | 2.245M |
| December 31, 2019 | 1.376M |
| September 30, 2019 | 3.613M |
| June 30, 2019 | 2.989M |
| March 31, 2019 | 2.838M |
| December 31, 2018 | 2.964M |
| September 30, 2018 | 2.992M |
| June 30, 2018 | 3.42M |
| March 31, 2018 | 3.132M |
| December 31, 2017 | 2.614M |
| September 30, 2017 | 3.319M |
| June 30, 2017 | 3.574M |
| March 31, 2017 | 3.266M |
| December 31, 2016 | 2.878M |
| September 30, 2016 | 3.104M |
| June 30, 2016 | 4.287M |
| March 31, 2016 | 3.736M |
| December 31, 2015 | 2.566M |
| September 30, 2015 | 2.152M |
| June 30, 2015 | 3.188M |
| March 31, 2015 | 0.977M |
| December 31, 2014 | 1.577M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 36.58M |
| Journey Medical Corp. | 10.11M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |